EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Clinical trials of pharmacological interventions for SARS‐CoV‐2 published in leading medical journals report adherence but not how it was assessed

Charlotte Lee iD, Afolarin Otunla iD, Isabelle Brennan, Jeffrey K Aronson iD, David Nunan iD

British Journal of Clinical Pharmacology · 2024

DOI: 10.1111/bcp.15992 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, 2024. Verfasst von Charlotte Lee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Evidence Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK. Hauptthemen laut MEDLINE: COVID-19, Periodicals as Topic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Adherence to pharmacological interventions in clinical trials is crucial for accurate identification of beneficial and adverse outcomes. The ways in which adherence to interventions should be reported in trial publications are described in the Template for Intervention Description and Replication (TIDieR), a 12‐item extension of the Consolidated Standards of Reporting Trials reporting guidelines. The objective of this study was to assess compliance with TIDieR Items 11 and 12 of randomized controlled trials (RCTs) of interventions in SARS‐CoV‐2 infection published in 5 selected journals during 2021.

Methods

We assessed pharmacological interventions for SARS‐CoV‐2 infection reported in RCTs published in 2021 in the Annals of Internal Medicine, The BMJ, JAMA, The Lancet and The New England Journal for Medicine for compliance with TIDieR items addressing intervention adherence (Items 11 and 12). We calculated proportional adherence for pharmacological and comparator interventions where available.

Results

We found 75 eligible RCTs. Twenty‐eight (37%) reported results of SARS‐CoV‐2 vaccinations. Compliance with Items 11 and 12 could be assessed in 71 of these 75. Of the 71 RCTs, 37 (52%) reported how adherence was assessed (Item 11), and 70 reported adherence rates (Item 12). Only 1 of the 71 RCTs (1.4%, 0–7.6%) fully complied with TIDieR Items 11 and 12.

Conclusion

Half of RCTs of SARS‐CoV‐2 pharmacological interventions published in leading medical journals in 2021 complied with reporting of how adherence assessments were made and almost none complied with both TIDieR Items 11 and 12. The implications for interpretation, application and replication of findings based on these publications warrant consideration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Periodicals as TopicHumansSARS-CoV-2Guideline AdherenceResearch DesignRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

CONSORTTIDieRcoronavirusintervention adherencetreatment

Autor:innen und Institutionen

  • Centre for Evidence Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
  • University Division of Anaesthesia, Department of Medicine, University of Cambridge, Cambridge, UK.
  • School of Clinical Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
  • University College London Hospitals, NHS Foundation Trust, London, UK.
  • School of Clinical Medicine, University of Cambridge, Cambridge, UK.

ORCID-Profile: Charlotte Lee, Afolarin Otunla, Jeffrey K Aronson, David Nunan

Zitieren

APA

Lee, C., Otunla, A., Brennan, I., Aronson, J. K., & Nunan, D. (2024). Clinical trials of pharmacological interventions for SARS‐CoV‐2 published in leading medical journals report adherence but not how it was assessed. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.15992

Vancouver

Lee C, Otunla A, Brennan I, Aronson JK, Nunan D. Clinical trials of pharmacological interventions for SARS‐CoV‐2 published in leading medical journals report adherence but not how it was assessed. British Journal of Clinical Pharmacology. 2024. doi:10.1111/bcp.15992

BibTeX
@article{Lee2024,
  author = {Lee, Charlotte and Otunla, Afolarin and Brennan, Isabelle and Aronson, Jeffrey K and Nunan, David},
  title = {Clinical trials of pharmacological interventions for SARS‐CoV‐2 published in leading medical journals report adherence but not how it was assessed},
  journal = {British Journal of Clinical Pharmacology},
  year = {2024},
  doi = {10.1111/bcp.15992}
}
Kostenlos starten →